Metformin, statins and the risk and prognosis of endometrial cancer in women with type 2 diabetes
Abstract Endometrial cancer (EC) is the fifth most common female cancer worldwide and its incidence is increasing. The prognosis of EC is fairly good. Histologically, ECs are categorized into endometrioid and non-endometrioid subtypes. Lately, the idea of repurposing existing medications for the pr...
Main Author: | Arima, R. (Reetta) |
---|---|
Other Authors: | Puistola, U. (Ulla) |
Format: | Doctoral Thesis |
Language: | English |
Published: |
Oulun yliopisto
2019
|
Subjects: | |
Online Access: | http://urn.fi/urn:isbn:9789526223469 http://nbn-resolving.de/urn:isbn:9789526223469 |
Similar Items
-
The role of metformin and statins in ovarian and breast cancer in women with type 2 diabetes
by: Urpilainen, E. (Elina)
Published: (2019) -
Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study
by: Elina Urpilainen, et al.
Published: (2018-07-01) -
Gestational diabetes:metformin treatment, maternal overweight and long-term outcome
by: Ijäs, H. (Hilkka)
Published: (2015) -
Statin and metformin therapy in prostate cancer patients with hyperlipidemia who underwent radiotherapy: a population-based cohort study
by: Li K, et al.
Published: (2019-02-01) -
Metformin: from antidiabetic to cancer therapeutic
by: Javorski, Michael
Published: (2016)